Pimavanserin, a serotonin 2A receptor inverse agonist, for the treatment of Parkinson's disease psychosis

Herbert Y. Meltzer, Roger Mills, Stephen Revell, Hilde Williams, Ann Johnson, Daun Bahr, Joseph H. Friedman

Research output: Contribution to journalArticlepeer-review

193 Scopus citations

Fingerprint

Dive into the research topics of 'Pimavanserin, a serotonin 2A receptor inverse agonist, for the treatment of Parkinson's disease psychosis'. Together they form a unique fingerprint.

Medicine & Life Sciences